Collegium Pharmaceutical (COLL) EPS (Basic) (2014 - 2026)

Collegium Pharmaceutical has reported EPS (Basic) for 13 years, with the latest figure at -$0.46 in Q2 2026.

• On a quarterly basis, EPS (Basic) fell 223.09% year-over-year to -$0.46 in Q2 2026; TTM through Jun 2026 was $1.48, a 29.46% increase from a year earlier, with the FY2025 full-year figure at $1.98, down 7.51% from the prior year.
• EPS (Basic) was -$0.46 for Q2 2026 at Collegium Pharmaceutical, down from $0.45 in the prior quarter.
• The five-year high for EPS (Basic) was $1.0 in Q3 2025, with the low at -$0.51 in Q1 2023.
• Average EPS (Basic) over 5 years is $0.27, with a median of $0.38 recorded in 2023.
• The sharpest annual moves came in 2023 and 2026: EPS (Basic) surged 4457.19% in 2023, then slumped 223.09% in 2026.
• Over 5 years, EPS (Basic) stood at -$0.21 in 2022, then jumped by 544.83% to $0.95 in 2023, then tumbled by 58.97% to $0.39 in 2024, then surged by 37.74% to $0.54 in 2025, then tumbled by 186.67% to -$0.46 in 2026.
• The last three EPS (Basic) figures came in at -$0.46 (Q2 2026), $0.45 (Q1 2026), and $0.54 (Q4 2025), per Business Quant data.